- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00396760
Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery
The Influence of High-Dose Aprotinin and Tranexamic Acid on Bleeding Tendency and Allogeneic Blood Transfusion in Patients Undergoing Primary Aortic Valve Replacement or Coronary Artery Revascularization
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Excessive bleeding during and after cardiac surgery is a serious complication. It exposes patients to the risk of allogeneic blood transfusion or other blood products and the risk of mediastinal re-exploration.Antifibrinolytic drugs like aprotinin and tranexamic acid are proven to reduce bleeding tendency and transfusion requirement in cardiac surgery. The efficacy of these drugs is proven, especially for the unspecific proteinase inhibitor aprotinin, however, there are concerns about the safety and the high costs of this drug. There are only limited head-to-head comparisons of these two drugs.
In this double-blind, prospective, controlled study the efficacy of aprotinin and tranexamic acid is compared. Primary outcome is the 24 hours postoperative drainage blood loss and the percentage of patients requiring allogeneic blood transfusion during the hospital stay. Subgroups of patients undergoing CABG surgery or aortic valve replacement are predefined for combined and separate data analysis.The power of the study is calculated for this subgroup-analysis.
Secondary outcome measurements are molecular marker of activation of hemostasis up to the 5th postoperative day.
Study Type
Enrollment
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Munich, Germany, 80636
- German Heart Center Munich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- informed consent
- Patients undergoing primary CABG or Aortic valve replacement surgery
Exclusion Criteria:
- Previous sternotomy
- OPCAB surgery
- urgent/emergency operation
- Coumadin treatment
- previous aprotinin exposure
- preoperative renal impairment (Creatinine > 2 mg/dL)
- patients refusing blood transfusions
- no informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
24 hours postoperative drainage blood loss
|
incidence of allogeneic blood transfusion
|
Secondary Outcome Measures
Outcome Measure |
---|
activation of fibrinolysis and hemostasis
|
impairment of renal function
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wulf Dietrich, MD, PhD, Department of Anesthesiology, German Heart Center Munich
Publications and helpful links
General Publications
- Henry DA, Moxey AJ, Carless PA, O'Connell D, McClelland B, Henderson KM, Sly K, Laupacis A, Fergusson D. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2001;(1):CD001886. doi: 10.1002/14651858.CD001886.
- Diprose P, Herbertson MJ, O'Shaughnessy D, Deakin CD, Gill RS. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Br J Anaesth. 2005 Mar;94(3):271-8. doi: 10.1093/bja/aei044. Epub 2004 Dec 10.
- Royston D, Levy JH, Fitch J, Dietrich W, Body SC, Murkin JM, Spiess BD, Nadel A. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes. Anesth Analg. 2006 Nov;103(5):1082-8. doi: 10.1213/01.ane.0000238447.74029.f5.
- Dietrich W, Busley R, Kriner M. High-dose aprotinin in cardiac surgery: is high-dose high enough? An analysis of 8281 cardiac surgical patients treated with aprotinin. Anesth Analg. 2006 Nov;103(5):1074-81. doi: 10.1213/01.ane.0000238446.30034.c8.
- Lison S, Dietrich W, Braun S, Boehm J, Schuster T, Englhard A, Perchuc A, Spannagl M, Busley R. Enhanced thrombin generation after cardiopulmonary bypass surgery. Anesth Analg. 2011 Jan;112(1):37-45. doi: 10.1213/ANE.0b013e3181fc6df0. Epub 2010 Dec 2.
- Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Anesth Analg. 2008 Nov;107(5):1469-78. doi: 10.1213/ane.0b013e318182252b.
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1172/04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Bypass Graft Surgery
-
North Texas Veterans Healthcare SystemUnknownCoronary Artery Bypass Graft SurgeryUnited States
-
South Valley UniversityActive, not recruitingCoronary Artery Bypass Graft SurgeryEgypt
-
University of Sao PauloFundação ZerbiniCompletedCoronary Artery Bypass Graft SurgeryBrazil
-
Bayside HealthGriffith UniversityCompletedCoronary Artery Bypass Graft Surgery | Cardiac Valve SurgeryAustralia
-
Alexandria UniversityNot yet recruitingAnalgesia After Coronary Artery Bypass Graft Surgery
-
Yale UniversityRecruitingCoronary Artery Bypass Graft Surgery | Aortic Valve ReplacementUnited States
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...Trakya University Faculty of Medicine HospitalCompletedCardiac Surgery | Desflurane | Cardiopulmonary Bypass | Coronary Artery Bypass Graft Surgery | Brain Natriuretic Peptide | Outcome
-
University of JordanJordanian Royal Medical ServicesEnrolling by invitationCoronary Artery Bypass Graft Surgery | Mace | 30 Day MortalityJordan
-
St. Boniface HospitalCompletedPatients Waiting for Elective Coronary Artery Bypass Graft SurgeryCanada
-
Good Shepherd Integrated Healthcare SystemsCompletedCardiac Surgery | Valve Replacement | Stent | Coronary Artery Bypass Graft CABGUnited States
Clinical Trials on aprotinin or tranexamic acid
-
Icahn School of Medicine at Mount SinaiRecruiting
-
University of LiegeCompletedArthroplasty Complications | Hemorrhage Postoperative | Total Blood LossBelgium
-
London School of Hygiene and Tropical MedicineCompleted
-
Samsung Medical CenterUnknownBleeding | Transfusion Related ComplicationKorea, Republic of
-
Assiut UniversityCompleted
-
Thammasat UniversityCompleted
-
Ferring PharmaceuticalsCompleted
-
Ain Shams UniversityCompleted
-
Aswan University HospitalCompletedCesarean Section ComplicationsEgypt
-
London School of Hygiene and Tropical MedicineRawalpindi Medical CollegeCompletedPregnancy, High RiskPakistan, Zambia